
Sign up to save your podcasts
Or


Dr Benjamin Levy from Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial in Washington, DC, discusses important efficacy and safety data from 2024 related to the use of approved and investigational therapies for localized and advanced non-small cell lung cancer without a targetable mutation.
CME information and select publications here.
By Dr. Neil Love4.4
3030 ratings
Dr Benjamin Levy from Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial in Washington, DC, discusses important efficacy and safety data from 2024 related to the use of approved and investigational therapies for localized and advanced non-small cell lung cancer without a targetable mutation.
CME information and select publications here.

322 Listeners

40 Listeners

66 Listeners

75 Listeners

15 Listeners

17 Listeners

13 Listeners

0 Listeners

6 Listeners

119 Listeners

59 Listeners

125 Listeners

43 Listeners

27 Listeners

60 Listeners

86 Listeners

189 Listeners